ECCMID 2024: Late-breaking abstracts submission is now open!

Late-breaking abstracts must pertain to new data that has not been published and was generated after the regular ECCMID 2024 abstracts submission.

For this year, we will exclusively consider abstracts in the following categories:

• New drugs and vaccines
• Clinical trials
• New and emerging pathogens
• Outbreaks and public health emergencies

Submission deadline is 14 February 2024, without possibility of extension.

Submit your late-breaking abstract here

You still have time to save on the ECCMID registration fee with Early Bird rates until 14 February 2024.

Register here for ECCMID 2024

14 February 2024 | Deadline

14 February 2024 | Deadline

14 February 2024 | Deadline

29 Feb 2024 | Deadline

You still have time to form your groups of four persons to participate in Selective Pressure. All ECCMID 2024 attendees are welcome to join this session for an interactive educational and entertaining experience. The moderator of the session is Prof. Jesús Rodríguez-Baño.

Deadline for creating groups is 14 February 2024.

Submit your group here

The focus of this course is helping professionals understand the basics and needs for AMS, as well as to develop and implement an AMS programme relevant to their setting

Register now

Following a statement of the BioMed Alliance about concerns regarding the availability of In Vitro Diagnostic Devices (IVDs) in Europe, the European Commission published a proposal to increase the time for companies to apply for the In Vitro Diagnostic Medical Devices Regulation (IVDR), under certain conditions. This is an important step towards ensuring patient care by improving the availability of these essential healthcare products.

Read more

The ESCMID Guidelines Subcommittee invites ESCMID members and ESCMID Study Groups to submit proposals for clinical practice guidelines projects in the following topics:

• Infection control and ICU standard procedures to reduce VAP
• Diagnosis and treatment of endovascular graft infections
• Diagnosis and treatment of Q fever

Deadline for project submission is 3 April 2024.

Read more

The full ECCMID 2024 Art Book is available now on the ECCMID website. We received an outstanding number of over 150 pieces of original art, which will be shared with the ECCMID community during the congress, both onsite and in the published online book.

View the Art Book here

The ESCMID Newsletter is issued on behalf of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) by the ESCMID Executive Office. It contains announcements of ESCMID-related matters and other information of interest to professionals in the infection field.

Tip: To ensure that you receive the ESCMID newsletter in your inbox, add newsletter@escmid.org to your email program's address book.

You have received this email as a contact of ESCMID or one of its affiliated societies. You can unsubscribe or change your newsletter subscriptions here.

Disclaimer

Privacy Notice

Contact